%0 Journal Article %T The first attempt worldwide to test PD-1 antibody on multiple “Stage 0” lung cancer %A Office, Editorial %J Translational Lung Cancer Research %D 2019 %B 2019 %9 %! The first attempt worldwide to test PD-1 antibody on multiple “Stage 0” lung cancer %K %X The editorial board recently noticed that a Chinese research team had launched a phase II, prospective, Simon’s two-stage design study which evaluates the efficacy and safety of PD-1 antibody Sintilimab on unresectable early-stage multiple primary lung cancer (MPLC) with ground-glass density (CCTC-1901, NCT04026841) ( Figure 1 ). This is the first documented study worldwide to test PD-1 antibody on “Stage 0” lung cancer, on July 24, 2019. %U https://tlcr.amegroups.org/article/view/30588 %V 8 %N 4 %P 556-557 %@ 2226-4477